Leonteq Securities AG Invests $1.43 Million in McKesson Corporation $MCK

Leonteq Securities AG purchased a new position in McKesson Corporation (NYSE:MCK) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 1,741 shares of the company’s stock, valued at approximately $1,428,000.

Other institutional investors and hedge funds also recently modified their holdings of the company. GGM Financials LLC bought a new position in shares of McKesson in the third quarter worth $25,000. State of Wyoming bought a new position in shares of McKesson in the second quarter worth $29,000. Hopwood Financial Services Inc. bought a new position in shares of McKesson in the third quarter worth $31,000. Vermillion & White Wealth Management Group LLC bought a new position in shares of McKesson in the third quarter worth $33,000. Finally, Board of the Pension Protection Fund bought a new position in shares of McKesson in the fourth quarter worth $33,000. Institutional investors own 85.07% of the company’s stock.

McKesson Stock Up 1.4%

Shares of MCK stock opened at $764.90 on Friday. The stock has a 50-day simple moving average of $841.61 and a 200 day simple moving average of $856.17. McKesson Corporation has a fifty-two week low of $637.00 and a fifty-two week high of $999.00. The stock has a market capitalization of $91.94 billion, a P/E ratio of 19.88, a P/E/G ratio of 1.12 and a beta of 0.35.

McKesson (NYSE:MCK) last announced its earnings results on Thursday, May 7th. The company reported $11.69 earnings per share for the quarter, beating the consensus estimate of $11.56 by $0.13. McKesson had a negative return on equity of 345.35% and a net margin of 1.18%.The business had revenue of $96.30 billion during the quarter, compared to analysts’ expectations of $101.35 billion. During the same quarter last year, the business posted $10.12 earnings per share. The company’s quarterly revenue was up 6.0% on a year-over-year basis. McKesson has set its FY 2027 guidance at 43.800-44.600 EPS. On average, sell-side analysts anticipate that McKesson Corporation will post 44.29 earnings per share for the current year.

McKesson Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 1st. Investors of record on Monday, June 1st will be given a $0.82 dividend. The ex-dividend date is Monday, June 1st. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.4%. McKesson’s dividend payout ratio (DPR) is 8.53%.

Insider Buying and Selling at McKesson

In related news, EVP Michele Lau sold 2,725 shares of the stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $990.00, for a total value of $2,697,750.00. Following the completion of the transaction, the executive vice president owned 3,247 shares in the company, valued at $3,214,530. This trade represents a 45.63% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.08% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on the company. Wells Fargo & Company decreased their price target on McKesson from $925.00 to $812.00 and set an “equal weight” rating for the company in a research note on Tuesday, May 12th. William Blair started coverage on McKesson in a research note on Tuesday, April 28th. They set an “outperform” rating for the company. Raymond James Financial set a $970.00 target price on McKesson in a research note on Thursday, March 5th. Leerink Partners reaffirmed an “outperform” rating and set a $1,085.00 target price on shares of McKesson in a research note on Thursday, March 5th. Finally, Weiss Ratings cut McKesson from a “buy (b+)” rating to a “buy (b)” rating in a research note on Monday. Fourteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, McKesson presently has a consensus rating of “Moderate Buy” and an average price target of $968.87.

McKesson Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.